EcoDrugPlus

Thymidylate Synthase

Ensembl ID : ENSMSIG00000012655
Gene Symbol: TYMS
1 Cross references
237 Possible Orthologues:

Thymoma Viral Proto-Oncogene 1

Ensembl ID : ENSMSIG00000028919
Gene Symbol: AKT1
1 Cross references
228 Possible Orthologues:

Thymoma Viral Proto-Oncogene 2

Ensembl ID : ENSMSIG00000027713
Gene Symbol: AKT2
1 Cross references
268 Possible Orthologues:

Thymoma Viral Proto-Oncogene 3

Ensembl ID : ENSMSIG00000008489
Gene Symbol: AKT3
1 Cross references
216 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSMSIG00000001348
Gene Symbol: THRB
1 Cross references
407 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSMSIG00000013587
Gene Symbol: TRHR
1 Cross references
281 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSMSIG00000019687
Gene Symbol: TLR2
1 Cross references
266 Possible Orthologues:

Toll-Like Receptor 4

Ensembl ID : ENSMSIG00000016362
Gene Symbol: TLR4
1 Cross references
142 Possible Orthologues:

Toll-Like Receptor 8

Ensembl ID : ENSMSIG00000021256
Gene Symbol: TLR8
1 Cross references
215 Possible Orthologues:

Toll-Like Receptor 9

Ensembl ID : ENSMSIG00000011095
Gene Symbol: TLR9
1 Cross references
97 Possible Orthologues:

Topoisomerase (Dna) I

Ensembl ID : ENSMSIG00000015267
Gene Symbol: TOP1
1 Cross references
285 Possible Orthologues:

Topoisomerase (Dna) Ii Alpha

Ensembl ID : ENSMSIG00000026083
Gene Symbol: TOP2A
1 Cross references
224 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).